Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled, Double Blind Study to Evaluate the Efficacy and Safety of Nidadd in the Management of Hyperlipidemia

NCT00244231 is registered in ClinicalTrials.gov with Genovate Biotechnology Co., Ltd., as lead sponsor.

NCT NCT00244231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled, Double Blind Study to Evaluate the Efficacy and Safety of Nidadd in the Management of Hyperlipidemia
Lead sponsor
Genovate Biotechnology Co., Ltd.,
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2003
Completion date
August 31, 2005
Enrollment
70
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia